{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:20:54Z","timestamp":1758417654183,"version":"3.44.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Health Research Institute La Fe Hospital","award":["2017\/0351"],"award-info":[{"award-number":["2017\/0351"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jns.2018.08.027","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T17:20:09Z","timestamp":1535476809000},"page":"140-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Lenalidomide induced reversible parkinsonism, dystonia, and dementia in subclinical Creutzfeldt-Jakob disease"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8537-1318","authenticated-orcid":false,"given":"H.","family":"Argente-Escrig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Balaguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Sevilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bataller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2018.08.027_bb0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ana.410050212","article-title":"Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering","volume":"5","author":"Masters","year":"1979","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2018.08.027_bb0010","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/mds.22497","article-title":"Thalidomide induced acute worsening of Parkinson's disease","volume":"24","author":"Crystal","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.08.027_bb0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/2050-6511-14-41","article-title":"Memory loss during lenalidomide treatment: a report on two cases","volume":"14","author":"Rollin-Sillaire","year":"2013","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.jns.2018.08.027_bb0020","article-title":"Novel insights into the mechanism of action of lenalidomide","volume":"1","author":"Semeraro","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jns.2018.08.027_bb0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fnagi.2014.00198","article-title":"Subtype and regional-specific Neuroinflammation in sporadic Creutzfeldt\u2013Jakob disease","volume":"6","author":"Llorens","year":"2014","journal-title":"Front. Aging Neurosci."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18303484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18303484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:46:33Z","timestamp":1758383193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18303484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":5,"alternative-id":["S0022510X18303484"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.08.027","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lenalidomide induced reversible parkinsonism, dystonia, and dementia in subclinical Creutzfeldt-Jakob disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}